fig2
![Progress in the treatment of NK-cell lymphoma/leukemia](https://image.oaes.cc/1142e3db-91fe-48c3-aabb-d98f40c1362b/4376.fig.2.jpg)
Figure 2. The scheme of molecular pathways and promising treatments for ENKL patients. LMP: Latent membrane protein; EBV: Epstein-Barr virus; HDAC: histone deacetylase.
Figure 2. The scheme of molecular pathways and promising treatments for ENKL patients. LMP: Latent membrane protein; EBV: Epstein-Barr virus; HDAC: histone deacetylase.
All published articles are preserved here permanently:
https://www.portico.org/publishers/oae/